Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001211583-07-000065
Filing Date
2007-12-05
Accepted
2007-12-05 15:48:20
Documents
1
Period of Report
2007-12-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 4  
1 PRIMARY DOCUMENT doc.xml 4 3933
  Complete submission text file 0001211583-07-000065.txt   5776
Mailing Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703
Business Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703 919-484-8484
ADHEREX TECHNOLOGIES INC (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address INNOVATIVE DRUG DELIVERY SYSTEMS, INC. 130 WEST 42ND STREET, 12TH FLOOR NEW YORK NY 10036
Business Address (212) 554-4550
Mermelstein Fred H (Reporting) CIK: 0001311357 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 071286723